(Press-News.org) November 16, 2023, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, signed an MOU yesterday with University of Cambridge (UCAM), University of Hong Kong (HKU), and the Hong Kong Jockey Club (HKJC) to promote vaccine research and global health initiatives, including the establishment of the Hong Kong Jockey Club Global Health Institute (HKJCGHI).
HKJC will support the HKJCGHI through one of their largest donations in history, aiming to advance vaccine research and development, particularly for pathogens of pandemic potential, while offering a robust training and education program for post-graduate students and future public health leaders. Leveraging their respective strengths, the founding partners seek to establish a center specialized in vaccine process and platform development, epidemiology, immunology, health economics, and capacity-building.
With a commitment to strengthening pandemic preparedness and regional prevention and control of infectious diseases, HKJCGHI will bring the latest translational vaccine technology to Hong Kong and bolster local and regional vaccine industries.
George Bickerstaff, Chairperson of IVI’s Board of Trustees, said: “We are incredibly excited to join forces with the University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to create a vital new hub for vaccine science and education. The founding of the Hong Kong Jockey Club Global Health Institute is an exemplar of positive partnership between research, academia, and philanthropy coming together for public good. IVI is grateful to the Hong Kong Jockey Club for the support and opportunity to take part in this essential effort.”
Michael Lee, Chairman of HKJC, said: “Hosted by the University of Hong Kong, the Hong Kong Jockey Club Global Health Institute will bring world-leading scientists and research teams from the International Vaccine Institute and the University of Cambridge to Hong Kong to work on translational vaccine research. With vaccines being the most powerful means of disease control, we want it to become a platform for fostering collaboration and cross-pollination of cutting-edge technologies.”
Dr. Jerome Kim, Director General of IVI, said: “IVI is proud to collaborate with the University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to create a global center at the cutting edge of vaccine R&D and training. With an emphasis on translational research, public-private partnership, and capacity-building, HKJCGHI aims to advance the access and affordability of critical vaccine technologies ahead of future pandemics. We look forward to integrating the institute into the broader global health ecosystem.”
The MOU signing ceremony took place on the campus of HKU with the signatures of Mr. Winfried Engelbrecht-Bresges, CEO, HKJC; Prof. Xiang Zhang, President and Vice-Chancellor, HKU; Prof. Patrick Maxwell, Regius Professor of Physics and Head of School, School of Clinical Medicine, UCAM; and Dr. Jerome H. Kim, Director General, IVI.
Mr. George Bickerstaff, Chairperson of IVI’s Board of Trustees, attended the ceremony as well as Ms. Lily Li, IVI Board Member and CEO and Founder of Harvard Wealth Strategy and Management, and Dr. Florian Marks, Deputy Director General of Epidemiology, Public Health, and Impact at IVI.
About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.
IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO), and developed a new-generation typhoid conjugate vaccine that is currently under assessment for WHO PQ.
IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.
Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | firstname.lastname@example.org
IVI signs MOU with University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to establish the Hong Kong Jockey Club Global Health Institute
ELSE PRESS RELEASES FROM THIS DATE:
Incidence of recurrence and time to recurrence in Stage I to III colorectal cancer
About The Study: In this study of 34,000 patients with colorectal cancer (CRC) who underwent surgery from 2004 to 2019, the risk of recurrence decreased over time, and higher disease stage was associated with shorter times from surgery to recurrence. Screening-detected CRC was associated with a lower risk of recurrence. Because the risk of recurrence was so low in selected patient groups, future research is warranted to explore risk-stratified surveillance protocols in patients with CRC. Authors: Claus Lindbjerg Andersen, Ph.D., of Aarhus University Hospital in Aarhus, Denmark, ...
New efforts to improve cardiovascular, stroke care in rural areas
DALLAS, November 16, 2023 — Cardiovascular mortality is on the rise in rural areas of the United States, where more than 60 million Americans live, according to an American Heart Association presidential advisory. Understanding and addressing the unique health needs of people in rural America is critical to the Association’s pursuit of a world of longer, healthier lives. Today — on National Rural Health Day — the Association, the world’s leading nonprofit organization focused on heart and brain health for all, announces two new collaborative efforts to help close the gap between ...
Make a list, check it twice with these heart-healthy holiday travel hacks
DALLAS, Nov. 16, 2023 — For people living with a health condition like heart disease or stroke, traveling away from home can pose some special challenges. The American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives for all, says with a little pre-travel prep, you can turn travel woes from “oh no” to “let’s go!” “As we look forward to the holidays, many people will be traveling to spend treasured time with family and friends, or maybe just to enjoy some ...
Two new clinical trials find first-ever safe and effective treatment to prevent multidrug-resistant TB in both children and adults: Results presented at the Union Conference in Paris
PARIS (16 November, 2023)—Two landmark clinical trials reported today at the Union meeting showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing drug-resistant TB. The antibiotic levofloxacin safely reduced the risk of multidrug-resistant (MDR) tuberculosis (TB) disease in children by 56%, researchers from the Desmond Tutu TB Centre at Stellenbosch University announced at the Union Conference in Paris today. The Unitaid-funded trial also showed that levofloxacin given once ...
AI model can help predict survival outcomes for patients with cancer
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types. The researchers found that by examining the gene expression patterns of epigenetic factors — factors that influence how genes are turned on or off — in tumors, they could categorize them into distinct groups to predict patient outcomes across various cancer types better than traditional measures like cancer grade and stage. These findings, described in Communications Biology, also lay the groundwork ...
Wearable devices detect circadian disturbances that predict frailty risk in older adults
Brigham researchers found an association between alterations in circadian rest-activity rhythms and risk of frailty incidence in older adults Wearable devices can be used to measure a variety of signs and signals related to our health. A new study by researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests that such devices may also be able to help predict older adults at risk of health complications related to frailty. The team found an association between disturbances in daily patterns of rest and activity, or circadian ...
Inequality hotspot map shows where women in agriculture are hit the hardest by the climate crisis
Threats posed by the climate crisis disproportionally affect certain communities and social groups that are more exposed. People living in low- and middle-income (LMIC) countries are at heightened risk. Within these countries, women typically face higher climate risk than men. To show where women working in agri-food systems – systems that encompass production, but also post-harvest handling and distribution – are most threated by climate change, an international team of researchers has developed a hotspot map that identifies and ranks localities by threat level. “We show that significant ...
Reclaiming carbon fibers from discarded composite materials
Minimizing energy consumption is a fundamental element in our journey towards sustainable societies, and advanced materials play a key role in this regard. Carbon-fiber-reinforced plastics (CFRPs) and carbon-fiber-reinforced thermoplastics (CFRTPs) are two prominent examples of composite materials that can significantly improve energy efficiency in various fields of application. These composites are made of carbon fibers embedded in a polymer matrix, such as epoxy resin. Thanks to their low weight and remarkable mechanical strength, CFRPs and CFRTPs can greatly ...
Break free from dependence on Japan by developing core electric vehicle components
A research team led by Dr. Jae-woong Ko from the Department of Engineering Ceramics at the Korea Institute of Materials Science(KIMS) has succeeded in localizing silicon nitride bearing ball manufacturing technology for electric vehicle drive modules. KIMS is a government-funded research institute under the Ministry of Science and ICT. This achievement is significant because it overcomes the limitations of foreign dependence and opens up the possibility of domestic supply and demand. Silicon nitride bearing ...
Cannabis use during pregnancy is associated with adverse birth outcomes
Infants prenatally exposed to cannabis are more likely to be born preterm, have a low birth weight, and require neonatal intensive care unit (NICU) care than infants without prenatal cannabis exposure, according to a study published today in the scientific journal Addiction. However, cannabis-exposed infants are not at greater risk of birth defects or death within one year, including sudden unexpected infant death. First author Ms. Maryam Sorkhou comments, “The global increase in cannabis use among women of reproductive age also extends to pregnant women. ...